Improved delivery of cromolyn from oral proliposomal beads

International Journal of Pharmaceutics

Volumn 358, Issue 1-2, 2008, Pages 128-136

  Deshmukh, Deepali D ^a   Ravis, William R ^a   Betageri, Guru V ^b  

^a AUBURN UNIVERSITY   (United States)

^b WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

Author keywords

Caco 2; Cromolyn; Intestinal sac; Proliposomal beads; Transport

Indexed keywords

CHOLIC ACID; CROMOGLYCATE DISODIUM; LIPOSOME; PHOSPHOLIPID DERIVATIVE; POLYSORBATE 80; SURFACTANT;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL DISRUPTION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; ENCAPSULATION; MONOLAYER CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT; TIGHT JUNCTION;

ANIMALS; ANTI-ASTHMATIC AGENTS; CACO-2 CELLS; CAPSULES; CHEMISTRY, PHARMACEUTICAL; CHOLESTEROL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROMOLYN SODIUM; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; EPITHELIAL CELLS; HUMANS; INTESTINES; LIPOSOMES; MALE; NANOPARTICLES; PARTICLE SIZE; PHOSPHOLIPIDS; POLYSORBATES; RATS; RATS, SPRAGUE-DAWLEY; SODIUM CHOLATE; SOLUBILITY; TABLETS;

EID: 44649202724     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.02.026     Document Type: Article

References (43)

1. Adson A., Raub T.J., Burton P.S., Barsuhn C.L., Hilgers A.R., Audus K.L., and Ho N.F.H. Quantitative approaches to delineate paracellular diffusion in cultured epithelial cell monolayers. J. Pharm. Sci. 83 (1994) 1529-1536
2. Alkan-Onyuskel H., and Son K. Mixed micelles as proliposomes for the solubili zation of teniposide. Pharm. Res. 9 (1992) 1556-1662
3. Almog S., Kushnir T., Nir S., and Lichenberg D. Kinetic and structural aspects of reconstitution of phophatidylcholine vesicles by dilution of phosphatidylcholine-sodium cholate mixed micelles. Biochemistry 25 (1986) 2597-2605
4. Arien A., Goigouux C., Baquey C., and Dupuy B. Study of in vitro and in vivo stability of liposomes loaded with calcitonin or indium in the gastrointestinal tract. Life Sci. 53 (1993) 1279-1290
5. Artursson P., Palm K., and Luthman K. Caco-2 monolayers in experimental and theoretical predictions of drug transport. Adv. Drug Deliv. Rev. 46 (2001) 27-43
6. Aungst B.J. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism. J. Pharm. Sci. 82 (1993) 979-987
7. Betageri G.V. Liposomal encapsulation and stability of dideoxyinosine triphosphate. Drug Dev. Ind. Pharm. 19 (1993) 531-539
8. Cevc G., Schatzlein A., Gebauer D., and Blume G. Ultra-high efficiency of drug and peptide transfer through intact skin by menas of novel drug-carriers, transferosomes. In: Brain K.R., James V.A., and Walters K.A. (Eds). Prediction of Percutaneous Penetration, 3rd International Conference, 14-16 April, vol. 3b (1993), STS Publishing, Cardiff, UK 226-236
9. Cevc G., Schatzlein A., and Blume G. Transdermal drug carriers: basic properties, optimization and transfer efficiency in the case of epicutaneously applied peptides. J. Control. Rel. 36 (1995) 3-16
10. Chaudhari K.B., Labhasetwar V., and Dorle A.K. Liposomes as a carrier for oral administration of insulin: effect of formulation factors. J. Microencapsul. 11 (1994) 319-325
11. Dapergolas G., and Gregoriadis G. Hypoglycaemic effect of liposome entrapped insulin administered intragastrically into rats. Lancet 2 (1976) 824-827
12. Dipali S.R., Kulkarni S.B., and Betageri G.V. Comparative study of separation of non-encapsulated drug from unilamellar liposomes by various methods. J. Pharm. Pharmacol. 48 (1996) 1112-1115
13. El Maghraby G.M.M., Williams C.A., and Barry B.W. Oestradiol skin delivery from ultradeformable liposomes: refinement of surfactant concentration. Int. J. Pharm. 196 (2000) 63-74
14. Fukunaga M., Miller M.M., and Deftos L.J. Liposome-entrapped calcitonin and parathyroid hormone are orally effective in rats. Horm. Metab. Res. 23 (1991) 166-167
15. Hochman J., and Artursson P. Mechanisms of absorption enhancement and tight junction regulation. J. Con. Rel. 29 (1994) 253-267
16. Kaartenin M., Pentilla A., and Kovanen P.T. Mast cells of two types differing in neutral protease composition in the human aortic intima. Arterioscler. Thromb. 14 (1994) 966-972
17. Kokkona M., Kallinteri P., Fatouros D., and Antimisiaris S.G. Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid composition. Eur. J. Pharm. Sci. 9 (2000) 245-252
18. Kronberg B., Dahlman A., Carlfors J., Karlsson J., and Artursson P. Preparation and evaluation of sterically stabilized liposomes: colloidal stability, serum stability, macrophage, uptake, and toxicity. J. Pharm. Sci. 79 (1990) 667-671
19. Kulkarni S.B., Betageri G.V., and Singh M. Factors affecting microencapsulation of drugs in liposomes. J. Microencap. 12 (1995) 229-246
20. Kulkarni S.B., Singh M., and Betageri G.V. Encapsulation, stability and in vitro characteristics of lipososmal formulations of Colchicine. J. Pharm. Pharmacol. 49 (1997) 491-495
21. Leone-Bay A., Leipold H., Sarubbi D., Variano B., Rivera T., and Baughman R.A. Oral delivery of sodium cromolyn: preliminary studies in vivo and in vitro. Pharm. Res. 13 (1996) 222-225
22. Meaney C.M., and O'Driscoll. A comparison of the permeation enhancement potential of simple bile salt and mixed bile salt:fatty acid micellar systems using Caco-2 cell culture model. Int. J. Pharm. 207 (2000) 21-30
23. Mineo H., Hara H., Shigematsu N., Okuhara Y., and Tomita F. Melibiose, Difructose Anhydride III and Difructose Anhydride IV enhance net calcium absorption in rat small and large intestinal epithelium by increasing the passage of tight junctions in vitro. Nut. Interact. Tox. 132 (2002) 3394-3399
24. Mori T., Nishimura K., Tamaki S., Nakamura S., Tsuda H., and Kakaya N. Prodrugs for the oral delivery of disodium cromoglycate. Chem. Pharm. Bull. 36 (1988) 338-344
25. Muranishi S., Muranishi N., and Sezaki H. Improvement of absolute bioavailability of normally poorly absorbed drugs: inducement of the intestinal absorption of streptomycin and gentamycin by lipid-bile salt mixed micelles in rat and rabbit. Int. J. Pharm. 2 (1979) 101-111
26. Olivion M., Lesieur S., Gabrielle-Madelmont C., and Paternostre M. Vesicle reconstitution from lipid-detergent mixed micelles. Biochim. Biophys. Acta 1508 (2000) 34-50
27. Payne N.I., Timmins P., Ambrose C.V., Ward M.D., and Ridgway F. Proliposomes: a novel solution to an old problem. J. Pharm. Sci. 75 (1986) 325-329
28. Planas M.E., Gonzalez P., Rodriguez L., and Sanchez G. Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier and prolongation of local pain insensitivity by anesthetic liposomes. Anest. Analg. 75 (1992) 615-621
29. Ravis W.R., and Feldman S. Effect of enzyme-inducing and enzyme-inhibiting agents on drug absorption I: 3-O-methylglucose transport in rats. J. Pharm. Sci. 67 (1978) 245-248
30. Rowland R.N., and Woodley J.F. The stability of liposomes in vitro to pH, bile salts and pancreatic lipase. Biochim. Biophys. Acta 620 (1980) 400-409
31. Rowland R.N., and Woodley J.F. The uptake of distearoylphosphatidylcholine/cholesterol liposomes by rat intestinal sacs in vitro. Biochim. Biophys. Acta 673 (1981) 217-223
32. Rowland R.N., and Woodley J.F. Uptake of free and liposome-entrapped insulin by rat intestinal sacs in vitro. Biosci. Rep. 1 (1981) 345-352
33. Rowland R.N., and Woodley J.F. Uptake of free and liposome-entrapped horseradish peroxide by rat intestinal sacs in vitro. FEBS Lett. 123 (1981) 41-44
34. Sarbalouki M.N., Parsaee S., and Kosary P. Mixed micelle proliposomes for preparation of liposomes containing amphotericin B, in vitro and ex vivo studies. PDA J. Pharm. Sci. Tech. 54 (2000) 240-246
35. Son K., and Alkan H. Liposomes prepared dynamically by interactions between bile salts and phospholipid molecules. Biochim. Biophys. Acta 981 (1989) 288-294
36. Schurtenberger P., Mazer N., and Kanzig W. Micelle to vesicle transition in aqueous-solutions of bile-salt and lecithin. J. Phys. Chem. 89 (1985) 1042-1049
37. Supersaxo A., Hein W.R., and Steffen H. Mixed micelles as a proliposomal lymphotropic drug carrier. Pharm. Res. 8 (1991) 1286-1291
38. Taylor K.M., Taylor G., Kellaway I.W., and Stevens J. The influence of liposomal encapsulation on sodium cromoglycate pharmacokinetics in man. Pharm. Res. 6 (1989) 633-636
39. Velardi A.L.M., Groen A.K., Elferink R.P.J.O., van der Meer R., Palasciano G., and Tygat G.N.J. Cell type-dependent effect of phospholipids and cholesterol on bile salt toxicity. Gastroentorology 101 (1991) 457-464
40. Vemuri S., and Rhodes C.T. Development and validation of a drug release rate method for a water soluble drug in a liposome preparation. Drug Dev. Ind. Pharm. 21 (1995) 1353-1364
41. Werner U., Kissel T., and Reers M. Effects of permeation enhancers on the transport of a Peptidomimetic Thrombin Inhibitor (CRC 220) in a human intestinal cell line (Caco-2). Pharm. Res. 13 (1996) 1219-1227
42. Yoshimi A., Hashizume H., Kitagawa M., Nishimura K., and Kakaya N. Characteristics of 1, 3-bis-(2-ethoxycarbonylchromon-5-yloxy)-2-((S)-lysyloxy)propane dihydrochloride (N-556), a prodrug for the oral delivery of sodium cromoglycate in absorption and excretion in rats and rabbits. J. Pharmacobiol. Dyn. 15 (1992) 681-686
43. Zou Y., Priebe W., and Soler-Perez R. Lyophilized preliposomal formulation of the non-cross-resistant anthracycline annamycin: effect of surfactant on liposome formation, stability and size. Cancer Chemother. Pharmacol. 39 (1996) 103-108